SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Acquisition

1 May 2015 07:00

RNS Number : 9497L
Oxford Instruments PLC
01 May 2015
 



 

Release date: 1 May 2015

 

Oxford Instruments plc

Acquisition of Medical Imaging Resources, Inc.

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

 

Founded in 1990 in Ann Arbor Michigan by CEO John Vartanian, MIR specialises in the build, lease and service of mobile medical imaging labs ("mobiles").

 

The mobile labs are built in MIR's factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba. These are leased to customers across the USA. MIR is also responsible for servicing its mobiles. Customers include hospitals and clinics that need additional capacity or that wish to trial MRI or CT machines without committing to the infrastructure and cost associated with a permanent unit.

 

MIR will form a part of OIHealthcare, within the Group's Service sector, which already services GE MRI and CT machines in the USA. There are a number of synergies with OIHealthcare:

 

· This will be a significant step to making OIHealthcare a multi-skilled independent service provider able to support large individual service contracts;

· Access to OIHealthcare's parts and its purchasing power for complete systems will lower MIR's operating costs;

· There will be overheads savings in those areas where duplication is eliminated;

· MIR currently sub-contracts a significant portion of the service work for its mobiles. OIHealthcare staff are located in numerous states and once trained will take over the work and will be able to bring the margin in-house.

 

Consideration, which will be satisfied from existing facilities, comprises $10.4 million (c. £6.8 million) on completion followed by a further $10.1 million (c. £6.6 million) earn-out payable one year later. MIR has approximately $3.0 million (c. £2.0 million) net debt at completion.

 

In the year to 31 December 2014, MIR had sales of $16.6 million (c. £10.8 million), profit before tax of $2.8 million (c. £1.8 million) and EBITDA of $5.6 million (c. £3.6 million). At 31 December 2014, MIR had gross assets of $9.4 million (c. £6.1 million).

 

 

 

Jonathan Flint (Chief Executive) and Kevin Boyd (Finance Director) will host a conference call for analysts and investors on this announcement at 9:30 am (UK time), today 1 May. To join the call, please use the dial-in numbers below:

 

Dial: +44 (0)20 3139 4830

PIN: 89662683#

 

 

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Jack Holden

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University, Oxford Instruments objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAFLEDSDSEAF
Date   Source Headline
30th Sep 20148:38 amPRNHolding(s) in Company
16th Sep 20149:10 amRNSDirector Declaration
12th Sep 20148:46 amPRNDirector/PDMR Shareholding
11th Sep 201412:19 pmPRNResult of AGM
11th Sep 20147:00 amRNSNotice of Site Visit
9th Sep 20147:00 amRNSAGM Statement
2nd Sep 20141:44 pmPRNAppointment of Non-Executive Director
18th Aug 201410:20 amPRNHolding(s) in Company
13th Aug 20141:10 pmPRNDirector/PDMR Shareholding
4th Aug 201410:13 amPRNTotal Voting Rights
22nd Jul 20142:14 pmPRNDirector/PDMR Shareholding
16th Jul 20147:00 amRNSInterim Management Statement
14th Jul 201411:00 amRNSNotice of IMS
3rd Jul 20149:28 amPRNDirector/PDMR Shareholding
1st Jul 201412:43 pmPRNBlocklisting - Interim Review
1st Jul 201411:49 amPRNTotal Voting Rights
23rd Jun 20148:47 amPRNHolding(s) in Company
13th Jun 20144:39 pmPRNDirector/PDMR Shareholding
13th Jun 20144:33 pmPRNDirector/PDMR Shareholding
12th Jun 20142:14 pmPRNDirector/PDMR Shareholding
10th Jun 20147:00 amRNSFinal Results
2nd Jun 20142:51 pmPRNTotal Voting Rights
16th May 20149:00 amRNSNotice of Results
14th May 20144:32 pmPRNDirector/PDMR Shareholding
9th May 201410:18 amPRNDirector Declaration
1st May 20142:31 pmPRNTotal Voting Rights
30th Apr 20146:03 pmPRNHolding(s) in Company
23rd Apr 20141:17 pmPRNDirector/PDMR Shareholding
16th Apr 20141:59 pmPRNHolding(s) in Company
10th Apr 20147:00 amRNSPre-close Trading Update
4th Apr 20149:40 amPRNHolding(s) in Company
3rd Apr 201410:20 amPRNHolding(s) in Company
1st Apr 20142:45 pmPRNDirector/PDMR Shareholding
1st Apr 201411:06 amPRNTotal Voting Rights
25th Mar 201411:41 amPRNHolding(s) in Company
19th Mar 20148:37 amPRNHolding(s) in Company
3rd Mar 20143:19 pmPRNDirector/PDMR Shareholding
3rd Mar 201410:29 amPRNTotal Voting Rights
13th Feb 20147:00 amRNSInterim Management Statement
6th Feb 20142:34 pmPRNTotal Voting Rights
31st Jan 201410:03 amPRNDirector/PDMR Shareholding
30th Jan 20147:59 amRNSSqueeze-Out Of Outstanding Andor Shares
23rd Jan 20142:51 pmPRNHolding(s) in Company
23rd Jan 20142:12 pmPRNDirector Declaration
23rd Jan 201410:13 amPRNBlocklisting - Interim Review
22nd Jan 20147:59 amRNSOffer Declared Wholly Unconditional
14th Jan 20145:13 pmPRNHolding(s) in Company
10th Jan 20143:10 pmPRNDirector/PDMR Shareholding
10th Jan 201411:53 amRNSForm 8.5 (EPT/RI)-Andor Technology Plc
10th Jan 20148:15 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.